Resumo
Definição
História e exame físico
Principais fatores diagnósticos
- história familiar de SWA
- facilidade de formar hematomas e petéquias
Outros fatores diagnósticos
- infecções recorrentes
- eczema
- hematomas e petéquias
- linfadenopatia
- membranas timpânicas perfuradas
- sangramento grave
- infecção grave/com risco de vida
- autoimunidade
Fatores de risco
- portador de mutação do gene WAS materno
- sexo masculino
Investigações diagnósticas
Primeiras investigações a serem solicitadas
- hemograma completo com volume plaquetário
- análise da proteína WAS (WASp)
- análise da mutação gênica da proteína WAS (WASp)
Investigações a serem consideradas
- níveis de imunoglobulina
- respostas à vacina
- iso-hemaglutininas
- subgrupos de linfócitos
- ensaios de proliferação das células T
- testes da função hepática
- análise por reação em cadeia da polimerase para hepatite C
- testes de reação em cadeia da polimerase para adenovírus, vírus Epstein-Barr e citomegalovírus
- reservar soro e plasma
Algoritmo de tratamento
síndrome de Wiskott-Aldrich (SWA) atenuada
síndrome de Wiskott-Aldrich (SWA) clássica grave
Colaboradores
Autores
Siobhan Burns, MB BAO BCh, MRCPI (Paeds)
Reader and Consultant in Immunology
University College London
Department of Immunology
Royal Free Hospital
London
UK
Declarações
SB has received travel expenses for educational conferences from Baxalta US Inc. and CSL Behring. SB has received a consulting fee from CSL Behring for a talk given about the use of subcutaneous immunoglobulin. SB has received grant funding for research into immunoglobulin treatment for primary immunodeficiency from CSL Behring. SB is the author of articles cited in this topic.
Adrian Thrasher, PhD, MD, BS, FRCP, MRCPCH, FMedSci
Professor of Paediatric Immunology
Molecular Immunology Unit and Centre for Immunodeficiency
Institute of Child Health
University College London
London
UK
Declarações
AT has done consultancy work for Orchard Therapeutics and Autolus, and owns stock in both. AT was an expert witness for Ward Hadaway Solicitors for a case of Wiskott-Aldrich syndrome. He is an author of references cited in this topic.
Revisores
Phil Fischer, MD
Professor of Pediatrics
Mayo Clinic
Rochester
MN
Declarações
PF declares that he has no competing interests.
Deepak Kamat, MD, PhD
Professor of Pediatrics
Wayne State University
Vice Chair of Education
Director
Institute of Medical Education
The Carman and Ann Adams Department of Pediatrics
Children's Hospital of Michigan
Detroit
MI
Declarações
DK declares that he has no competing interests.
Referências
Principais artigos
O'Sullivan E, Kinnon C, Brickell P. Wiskott-Aldrich syndrome protein, WASP. Int J Biochem Cell Biol. 1999;31:383-387. Resumo
Imai K, Morio T, Zhu Y, et al. Clinical course of patients with WASP gene mutations. Blood. 2004;103:456-464.Texto completo Resumo
Imai K, Morio T, Zhu Y, et al. Clinical course of patients with WASP gene mutations. Blood. 2004;103:456-464.Texto completo Resumo
Burns S, Cory GO, Vainchenker W, et al. Mechanisms of WASp-mediated hematologic and immunologic disease. Blood. 2004;104:3454-3462.Texto completo Resumo
Filipovich AH, Stone JV, Tomany SC, et al. Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program. Blood. 2001;97:1598-1603.Texto completo Resumo
Artigos de referência
Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.
Diagnósticos diferenciais
- Trombocitopenia idiopática (TPI)
- Síndrome linfoproliferativa autoimune (SLPA)
Mais Diagnósticos diferenciaisDiretrizes
- COVID-19 vaccines for moderately or severely immunocompromised people
- EBMT/ESID inborn errors working party guidelines for hematopoietic stem cell transplantation for inborn errors of immunity
Mais Diretrizes
Conectar-se ou assinar para acessar todo o BMJ Best Practice
O uso deste conteúdo está sujeito ao nosso aviso legal